Skip to content

DWI Breast MRI in Dense Breast: A Clinical Trial to Assess the Efficacy and Diagnostic Accuracy of Diffusion Weighted Imaging in Dense Breast Tissue

DWI Breast MRI in Dense Breast: A Clinical Trial to Assess the Efficacy and Diagnostic Accuracy of Diffusion Weighted Imaging in Dense Breast Tissue

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06836089
Acronym
DWI-Breast MRI
Enrollment
350
Registered
2025-02-20
Start date
2025-01-01
Completion date
2026-01-31
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Detection, Dense Breast Parenchyma, DWI

Keywords

Breast MRI, DWI, dense breast

Brief summary

his clinical trial aims to evaluate the efficacy and diagnostic accuracy of Diffusion Weighted Imaging (DWI) in breast MRI for women with dense breast tissue. DWI is investigated as an adjunctive method to improve early tumor detection in women with dense breasts, a group at high risk for delayed diagnosis due to limited visibility in mammography. Study Purpose: To assess the utility of Diffusion Weighted Imaging (DWI) in improving diagnostic accuracy for patients with dense breasts.

Interventions

None listed

Sponsors

Link Campus University
CollaboratorOTHER
University of Campania Luigi Vanvitelli
CollaboratorOTHER
Graziella di Grezia
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women aged 40-75 years. * Patients with dense breast tissue, classified according to BI-RADS (Breast Imaging-Reporting and Data System). * Patients who previously underwent breast MRI, including Diffusion Weighted Imaging (DWI). * Availability of histopathological confirmation for breast lesions (biopsy results).

Exclusion criteria

* Patients with a known allergy to gadolinium-based contrast agents. * Pregnant or breastfeeding women at the time of imaging. * Presence of metallic implants or other MRI-incompatible devices. * Patients with incomplete imaging datasets (e.g., missing DWI sequences or non-standardized protocols). * Prior history of breast cancer treatment (surgery, chemotherapy, or radiotherapy) before the imaging study.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Diffusion Weighted Imaging (DWI) in Dense Breast Tissue: A Retrospective Cohort Study12 monthsThis retrospective cohort study aims to assess the diagnostic accuracy and clinical utility of Diffusion Weighted Imaging (DWI) in breast MRI for women with dense breast tissue. By analyzing previously collected imaging data, the study evaluates the sensitivity, specificity, and predictive value of DWI in detecting malignant breast lesions. The research also examines the correlation between Apparent Diffusion Coefficient (ADC) values and histopathological tumor characteristics, comparing DWI's performance with conventional MRI and mammography/tomosynthesis.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026